Bioimpedance Analysis in Chronic Heart Failure

Peter Studinger240 enrolled

Overview

The aim of this study is to investigate whether the objective measurement of fluid overload by bioimpedance analysis (Body Composition Monitor-BCM) in patient with acute decompensated heart failure would improve the diuretic therapy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

240

Conditions

Heart Failure

Interventions

Body Composition Monitor (BCM)DEVICE

In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with known or newly discovered chronic heart failure admitted to hospital because of the clinical signs of acut cardiac decompensation Exclusion Criteria: * High level of fatigue (the patient cannot stand on a scale) * Amputated upper and/or lower limb(s) * The BCM analysis is not possible technically (e.g. open wounds on the limbs) * Severe obesity (\>130 kg) * Patients on chronic hemodialysis or peritoneal dialysis * Severe fluid volume in the transcellular space * Patients with a unipolar pacemaker whose sensitivity threshold is very low * Pregnancy, lactation

Locations (1)

First Department of Medicine, Semmelweis University

Budapest, Hungary

Outcomes

Primary Outcomes

Re-hospitalization rate

Time frame: 12 months

Secondary Outcomes

All cause mortality

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.